Message from @Sasha
Discord ID: 652285898137796609
idk how
Does this make me black
What is being discussed?
@Deleted User @Neuron Cortex what do you think of my pfp?
Heartwarming and cute
i wish there was a way to make the still image move slightly each frame to not make the image still
@Hagar https://www.youtube.com/watch?v=bMdeg-WKt1U You dig this?
lemme see
sounds like stuff i'd listen when i'd travel or walk around thinking about stuff
@muhahahahe @Neuron Cortex @ᏉᎬᏁus ( ᵘ ᵕ ᵘ ⁎) pop in vc
Woah shit, server's alive. Just in time for me to have to leave <:pepehands:644890202304937994>
lol
<@591273450325409792>
😄
@Sasha tagged the wrong person
Don't think i did
you did
Who do you think i was trying to tag?
Venus
but i didnt
I meant to tag venny
?jail @Bully
?ban @Bully
@Castore what opioids?
@Master, remember the Athenians. https://www.nber.org/papers/w26500 ''Despite the importance of the opioid crisis and the desire to understand its origins, there
is little empirical work exploring its initial causes. We study the effects of the introduction of
OxyContin in 1996, exploiting early variation in its promotion and market entry based on preexisting state policies known as triplicate prescription programs. These state policies were
adopted decades earlier and became outdated soon after OxyContin's launch. However, their
initial deterrence of OxyContin promotion and use had long-term effects on overdoses in these
states, dramatically decreasing overdose death rates even today.
Our results imply striking differences throughout the opioid crisis stemming from
variation in initial policy conditions. '' ,
''We use our results to provide a back-of-the-envelope calculation of how much of the
dramatic growth in drug overdose deaths can be accounted for by the introduction and marketing
of OxyContin. On average, the national drug overdose death rate increased by 6.89 deaths per
100,000 since 1996, comparing the mean during the 1996-2017 time period (11.33 deaths per
100,000) relative to the 1991-1995 baseline mean (4.44). The additional exposure to
OxyContin’s launch and marketing for non-triplicate states led to 4.49 more deaths per 100,000,
which is equivalent to 65% (4.49/6.89) of the national growth in overdose death rates since
1996. As an additional benchmarking exercise, we consider the additional deaths that could be
attributed to an increase in initial OxyContin exposure moving from no exposure to the national
level of exposure. To make this calculation, we need to scale our mortality results by the
difference in OxyContin exposure between non-triplicate and triplicate states.66 This
extrapolation suggests that moving from no OxyContin exposure to the national average would
lead to 5.56 more deaths per 100,000, which is 81% of the rise in the overdose death rate since
1996. We note that this extrapolation is far out-of-sample since no part of the United States was
unexposed, so we interpret it with caution. However, these calculations suggest that exposure to
OxyContin may explain a large share of the growth in drug overdose deaths since the mid-1990s. ''
https://cdn.discordapp.com/attachments/373119138689974273/651477636568317962/unknown.png
I read somewhere that opioids effect the ventrolateral and orbitiofrontal prefrontal cortexes.